219 related articles for article (PubMed ID: 36060802)
1. An m5C methylation regulator-associated signature predicts prognosis and therapy response in pancreatic cancer.
Yun D; Yang Z; Zhang S; Yang H; Liu D; Grützmann R; Pilarsky C; Britzen-Laurent N
Front Cell Dev Biol; 2022; 10():975684. PubMed ID: 36060802
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Analysis of m5C Methylation Regulatory Genes and Tumor Microenvironment in Prostate Cancer.
Yu G; Bao J; Zhan M; Wang J; Li X; Gu X; Song S; Yang Q; Liu Y; Wang Z; Xu B
Front Immunol; 2022; 13():914577. PubMed ID: 35757739
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Risk Model and Tumor Immune Environment Modulation of m5C-Related LncRNAs in Pancreatic Ductal Adenocarcinoma.
Yuan H; Liu J; Zhao L; Wu P; Chen G; Chen Q; Shen P; Yang T; Fan S; Xiao B; Jiang K
Front Immunol; 2021; 12():800268. PubMed ID: 34956238
[TBL] [Abstract][Full Text] [Related]
4. m5C regulator-mediated modification patterns and tumor microenvironment infiltration characterization in colorectal cancer: One step closer to precision medicine.
Chen B; Xi Y; Zhao J; Hong Y; Tian S; Zhai X; Chen Q; Ren X; Fan L; Xie X; Jiang C
Front Immunol; 2022; 13():1049435. PubMed ID: 36532062
[TBL] [Abstract][Full Text] [Related]
5. Roles of m5C RNA Modification Patterns in Biochemical Recurrence and Tumor Microenvironment Characterization of Prostate Adenocarcinoma.
Xu Z; Chen S; Zhang Y; Liu R; Chen M
Front Immunol; 2022; 13():869759. PubMed ID: 35603206
[TBL] [Abstract][Full Text] [Related]
6. Identification and verification of an ALYREF-involved 5-methylcytosine based signature for stratification of prostate cancer patients and prediction of clinical outcome and response to therapies.
Tan X; Cai Z; Chen G; Cai C; Chen J; Liang Y; Zhuo Y; Liu J; Huang L; Ouyang B; Wei Y; Jia Z; Deng J; Zhong W; Lu J
Discov Oncol; 2023 May; 14(1):62. PubMed ID: 37155024
[TBL] [Abstract][Full Text] [Related]
7. 5-methylcytosine RNA methylation regulators affect prognosis and tumor microenvironment in lung adenocarcinoma.
Liu T; Hu X; Lin C; Shi X; He Y; Zhang J; Cai K
Ann Transl Med; 2022 Mar; 10(5):259. PubMed ID: 35402591
[TBL] [Abstract][Full Text] [Related]
8. Developing an m5C regulator-mediated RNA methylation modification signature to predict prognosis and immunotherapy efficacy in rectal cancer.
Zhang R; Gan W; Zong J; Hou Y; Zhou M; Yan Z; Li T; Lv S; Zeng Z; Wang W; Zhang F; Yang M
Front Immunol; 2023; 14():1054700. PubMed ID: 36911744
[TBL] [Abstract][Full Text] [Related]
9. The m6A/m5C/m1A Regulated Gene Signature Predicts the Prognosis and Correlates With the Immune Status of Hepatocellular Carcinoma.
Li D; Li K; Zhang W; Yang KW; Mu DA; Jiang GJ; Shi RS; Ke D
Front Immunol; 2022; 13():918140. PubMed ID: 35833147
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Significance and Tumor Immune Microenvironment Heterogenicity of m5C RNA Methylation Regulators in Triple-Negative Breast Cancer.
Huang Z; Pan J; Wang H; Du X; Xu Y; Wang Z; Chen D
Front Cell Dev Biol; 2021; 9():657547. PubMed ID: 33928086
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Analysis of the Prognostic Value and Immune Infiltrates of the Three-m5C Signature in Colon Carcinoma.
Geng Q; Wei Q; Shen Z; Zheng Y; Wang L; Xue W; Li L; Zhao J
Cancer Manag Res; 2021; 13():7989-8002. PubMed ID: 34707405
[TBL] [Abstract][Full Text] [Related]
12. Identification of M5c regulator-medicated methylation modification patterns for prognosis and immune microenvironment in glioma.
Xiao Z; Li J; Liang C; Liu Y; Zhang Y; Zhang Y; Liu Q; Yan X
Aging (Albany NY); 2023 Nov; 15(21):12275-12295. PubMed ID: 37934565
[TBL] [Abstract][Full Text] [Related]
13. The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature.
Zhou S; Sun Y; Chen T; Wang J; He J; Lyu J; Shen Y; Chen X; Yang R
Front Cell Dev Biol; 2021; 9():739594. PubMed ID: 34660598
[TBL] [Abstract][Full Text] [Related]
14. A novel immunogenomic signature to predict prognosis and reveal immune infiltration characteristics in pancreatic ductal adenocarcinoma.
Li A; Ye B; Lin F; Wang Y; Miao X; Jiang Y
Precis Clin Med; 2022 Jun; 5(2):pbac010. PubMed ID: 35694712
[TBL] [Abstract][Full Text] [Related]
15. Systematic Analysis of Tumor Microenvironment Patterns and Oxidative Stress Characteristics of Endometrial Carcinoma Mediated by 5-Methylcytosine Regulators.
Dong C; Dang L; Gao X; Xu R; Zhang H; Zhang X
Oxid Med Cell Longev; 2022; 2022():6431164. PubMed ID: 36187339
[TBL] [Abstract][Full Text] [Related]
16. m5C regulator-mediated methylation modification phenotypes characterized by distinct tumor microenvironment immune heterogenicity in colorectal cancer.
Chen Z; Li Q; Lin Y; Lin S; Gao J; Chen S
Sci Rep; 2023 Jul; 13(1):11950. PubMed ID: 37488178
[TBL] [Abstract][Full Text] [Related]
17. m5C methylation modification guides the prognostic value and immune landscapes in acute myeloid leukemia.
Liu Y; Chen Y; Cai M; Hong Y; Wu X; Li S
Aging (Albany NY); 2023 Sep; 15(18):9858-9876. PubMed ID: 37751592
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
Front Immunol; 2021; 12():669750. PubMed ID: 34054840
[TBL] [Abstract][Full Text] [Related]
19. Contribution of m5C RNA Modification-Related Genes to Prognosis and Immunotherapy Prediction in Patients with Ovarian Cancer.
Liu Y; Liu S; Yan L; Zhang Q; Liu W; Huang X; Liu S
Mediators Inflamm; 2023; 2023():1400267. PubMed ID: 38022687
[TBL] [Abstract][Full Text] [Related]
20. m5C RNA Methylation Regulators Predict Prognosis and Regulate the Immune Microenvironment in Lung Squamous Cell Carcinoma.
Pan J; Huang Z; Xu Y
Front Oncol; 2021; 11():657466. PubMed ID: 34195072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
